TY - JOUR
T1 - Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization
AU - Sonoda, Shozo
AU - Tachibana, Katsuro
AU - Uchino, Eisuke
AU - Yamashita, Toshifumi
AU - Sakoda, Kenji
AU - Sonoda, Koh Hei
AU - Hisatomi, Toshio
AU - Izumi, Yuichi
AU - Sakamoto, Taiji
PY - 2007/8
Y1 - 2007/8
N2 - Ultrasound exposure-induced cavitation has been shown to accentuate cell membrane permeability, thus promoting effective drug delivery into cells, a technique that can be enhanced in the presence of microbubbles (MB). Here we applied this method as a treatment for malignant melanoma of the eyelid. The incidence of malignant melanoma in ophthalmology is relatively high, but its treatment is cosmetically difficult. A greater in vitro growth suppression of B-16 melanoma cells was achieved using ultrasound and MB in combination with the anticancer drug bleomycin than when a more concentrated dose of bleomycin alone was applied to the cell culture. Moreover, this effect was enhanced in an in vivo tumor model created by injecting B-16 melanoma cells into the lower eyelids of SCID mice. The antitumor effect of bleomycin was observed at a lower dose (0.5 mg/ml) when the treatment was used in conjunction with ultrasound. The effect was further enhanced when MB were included, with tumor shrinkage occurring at bleomycin levels of 0.06 mg/ml. These results show that ultrasound and MB promote efficient bleomycin uptake by cells, and that the technique is a potentially useful drug delivery method.
AB - Ultrasound exposure-induced cavitation has been shown to accentuate cell membrane permeability, thus promoting effective drug delivery into cells, a technique that can be enhanced in the presence of microbubbles (MB). Here we applied this method as a treatment for malignant melanoma of the eyelid. The incidence of malignant melanoma in ophthalmology is relatively high, but its treatment is cosmetically difficult. A greater in vitro growth suppression of B-16 melanoma cells was achieved using ultrasound and MB in combination with the anticancer drug bleomycin than when a more concentrated dose of bleomycin alone was applied to the cell culture. Moreover, this effect was enhanced in an in vivo tumor model created by injecting B-16 melanoma cells into the lower eyelids of SCID mice. The antitumor effect of bleomycin was observed at a lower dose (0.5 mg/ml) when the treatment was used in conjunction with ultrasound. The effect was further enhanced when MB were included, with tumor shrinkage occurring at bleomycin levels of 0.06 mg/ml. These results show that ultrasound and MB promote efficient bleomycin uptake by cells, and that the technique is a potentially useful drug delivery method.
UR - http://www.scopus.com/inward/record.url?scp=39749084633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39749084633&partnerID=8YFLogxK
U2 - 10.4161/cbt.6.8.4485
DO - 10.4161/cbt.6.8.4485
M3 - Article
C2 - 17704642
AN - SCOPUS:39749084633
SN - 1538-4047
VL - 6
SP - 1282
EP - 1289
JO - Cancer Biology and Therapy
JF - Cancer Biology and Therapy
IS - 8
ER -